Vheda Health Closes Record 2025 with Market-Leading Outcomes, New Partnerships, and Workforce Growth

5 days ago

In 2025, Vheda Health achieved its largest growth on record - launching its chronic, behavioral health, and maternity programs across…

Pacira Announces Agreement with LG Chem to Make EXPAREL® Available in Select Asian-Pacific Markets

5 days ago

-- LG Chem becomes exclusive distributor of EXPAREL --  – Partnership expands patient access to opioid-sparing pain control and advances…

CytoMed Therapeutics’ new year update and seeks shareholders’ feedback on proposal to improve shareholder value for their patient capital

5 days ago

SINGAPORE, Jan. 13, 2026 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”), a Singapore-based clinical stage…

Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of James Hassard as Executive Vice President, Chief Commercial Officer

5 days ago

Seasoned leader with global commercialization and marketing expertiseSOUTH SAN FRANCISCO, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc.…

Konica Minolta Healthcare and deepc Partner to Bring AI to the Exa Platform

5 days ago

The companies have a shared vision to make medical imaging AI simpler, faster and more human Konica Minolta Healthcare and…

Dentsply Sirona Appoints Donald Zurbay to Board of Directors

5 days ago

Company’s Board of Directors forms Growth and Value Creation Committee to guide the Company’s Return-to-Growth Action PlanCHARLOTTE, N.C., Jan. 13,…

MediPharm Labs to Enter New Market with Costa Rica Supply Agreement

5 days ago

TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or…

Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company

5 days ago

Positions Lifeward as a MedTech platform with a clear path to cashflow positive and long-term Biotech upside potential Up to…

Cassava Announces Publication of Peer-Reviewed Phase 3 Results for Simufilam in Alzheimer’s Disease in the Journal of Prevention of Alzheimer’s Disease

5 days ago

As previously disclosed, the studies did not meet pre-specified co-primary, secondary, or exploratory biomarker endpoints  The paper provides a detailed…

Fedora Pharmaceuticals has Re-emerged to Unveil Novel Class of Antibiotics at 2026 Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI)

5 days ago

Edmonton, Alberta, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc., a leader in the development of drugs to treat…